论文部分内容阅读
本文就现行生产的浓缩狂犬病疫苗对暴露人群接种后，用ＥＬＩＳＡ法对血清学效果进行动态观察。结果表明接种疫苗前抗体均为阴性，注射第１针后的第４天、第７天和第１４天时阳转率分别为４０．００％、４３．００％和１００％；在第１４天时ＧＭＴ为２２８．１５，４５天时达到高峰为３３８．３３，９０天时稍有下降，显示了浓缩狂犬病疫苗的抗体产生早、水平高，维持时间长，对短潜伏期患者起到有效的保护作用。本文还对不同注射部位与不同年龄组进行了免疫效果的比较
In this paper, the current production of concentrated rabies vaccine on the exposed population vaccination, ELISA serological observation of the dynamic effect. The results showed that all the antibodies were negative before vaccination. The positive conversion rates were 40.00%, 43.00% and 100% on the 4th day, the 7th day and the 14th day after the first injection, respectively. On the 14th day, GMT At 228.15, reached a peak of 338.33 at 45 days, showing a slight decrease at 90 days. The results showed that the rabies vaccine with concentrated rabies vaccine produced early, high-level and long-lasting antibodies, which effectively protected patients with short latency. In this paper, different injection sites and different age groups were compared the immune effect